Praxis Precision Medicines, Inc. (PRAX) › Operating IncomePraxis Precision Medicines, Inc. (PRAX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$35.79M2020: -$61.97M2021: -$167.33M2022: -$214.99M2023: -$126.37M2024: -$200.16M2025: -$326.20M-$326.20M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$326.20M-63.0%2024-$200.16M-58.4%2023-$126.37M+41.2%2022-$214.99M-28.5%2021-$167.33M-170.0%2020-$61.97M-73.1%2019-$35.79M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share